Inflammatory bowel disease, which encompasses Crohn’s disease and ulcerative colitis, has undergone a transformation in management over the last decade. Early treatment to achieve mucosal healing and complete resolution of symptoms have become overarching treatment goals for IBD. The advent of a range of biologic drugs, in addition to a growing understanding of IBD pathogenesis and related comorbidities, highlight the need for CME that is current and practice-changing. Clinical Care Options provides up-to-date and evidence-based IBD CME that arms physicians, nurses, pharmacists, and other health care providers with the necessary tools to optimize care of their patients with IBD. Choose from a range of IBD CE courses in a variety of formats designed to deliver the most relevant information in the most accessible manner possible.